title: How do living kidney donors develop end-stage renal disease?
abstract: The clinical course and risk factors for developing end-stage renal disease (ESRD) after heminephrectomy in living kidney donors have scarcely been investigated. We reviewed medical records and identified eight case donors who developed chronic kidney disease (CKD) stage 5 or ESRD, and subsequently investigated the association between postoperative clinical courses and changes in renal function. To conduct a case-control study, we also selected a control group comprising 24 donors who had maintained stable renal function and were matched for age, sex and follow-up time since donation. Except for one donor who developed ESRD caused by a traffic accident, none of the donors developed progressive renal dysfunction immediately after donation. Their renal functions remained stable for a long period of time, but started to decline after developing new comorbidities, especially risk factors known as progression factors (proteinuria or hypertension) or accelerating factors (cardiovascular [CV] event or infection) of CKD. As compared with the control donors, incidence of postoperative persistent proteinuria, acute CV event, severe infection and hospitalization due to accelerating factors of CKD were significantly higher in the case donors. These results suggest the importance of long-term (more than 10 years) follow-up of donors with special attention on the risk factors of CKD.
authors.affiliation: Department of Nephrology and Endocrinology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan. Ryo.kido@mb5.seikyou.ne.jp
authors.forename: R
authors.initials: R
authors.lastname: Kido
authors.forename: Y
authors.initials: Y
authors.lastname: Shibagaki
authors.forename: K
authors.initials: K
authors.lastname: Iwadoh
authors.forename: I
authors.initials: I
authors.lastname: Nakajima
authors.forename: S
authors.initials: S
authors.lastname: Fuchinoue
authors.forename: T
authors.initials: T
authors.lastname: Fujita
authors.forename: S
authors.initials: S
authors.lastname: Teraoka
mesh_terms: D000368:Aged; D016022:Case-Control Studies; D003928:Diabetic Nephropathies / Q000453:epidemiology; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006977:Hypertension, Renal / Q000453:epidemiology; D007668:Kidney / Q000502:physiology; D007676:Kidney Failure, Chronic / Q000453:epidemiology*; D016030:Kidney Transplantation; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy / Q000009:adverse effects* / Q000706:statistics & numerical data; D011507:Proteinuria / Q000453:epidemiology; D012307:Risk Factors